These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 23350811)

  • 21. Ligand-based virtual screening and molecular docking studies to identify the critical chemical features of potent cathepsin D inhibitors.
    Sakkiah S; Thangapandian S; Lee KW
    Chem Biol Drug Des; 2012 Jul; 80(1):64-79. PubMed ID: 22269155
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protein flexibility in ligand docking and virtual screening to protein kinases.
    Cavasotto CN; Abagyan RA
    J Mol Biol; 2004 Mar; 337(1):209-25. PubMed ID: 15001363
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Microarrays of tagged combinatorial triazine libraries in the discovery of small-molecule ligands of human IgG.
    Uttamchandani M; Walsh DP; Khersonsky SM; Huang X; Yao SQ; Chang YT
    J Comb Chem; 2004; 6(6):862-8. PubMed ID: 15530111
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fast structure-based virtual ligand screening combining FRED, DOCK, and Surflex.
    Miteva MA; Lee WH; Montes MO; Villoutreix BO
    J Med Chem; 2005 Sep; 48(19):6012-22. PubMed ID: 16162004
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 1,3,5-Triazine as a modular scaffold for covalent inhibitors with streamlined target identification.
    Banerjee R; Pace NJ; Brown DR; Weerapana E
    J Am Chem Soc; 2013 Feb; 135(7):2497-500. PubMed ID: 23379904
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A hierarchical method for molecular docking using cloud computing.
    Kang L; Guo Q; Wang X
    Bioorg Med Chem Lett; 2012 Nov; 22(21):6568-72. PubMed ID: 23017886
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Discovery of potent thermolysin inhibitors using structure based virtual screening and binding assays.
    Khan MT; Fuskevåg OM; Sylte I
    J Med Chem; 2009 Jan; 52(1):48-61. PubMed ID: 19072688
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Virtual screening of biogenic amine-binding G-protein coupled receptors: comparative evaluation of protein- and ligand-based virtual screening protocols.
    Evers A; Hessler G; Matter H; Klabunde T
    J Med Chem; 2005 Aug; 48(17):5448-65. PubMed ID: 16107144
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of new Fyn kinase inhibitors using a FLAP-based approach.
    Poli G; Tuccinardi T; Rizzolio F; Caligiuri I; Botta L; Granchi C; Ortore G; Minutolo F; Schenone S; Martinelli A
    J Chem Inf Model; 2013 Oct; 53(10):2538-47. PubMed ID: 24001328
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An integrative in silico methodology for the identification of modulators of macrophage migration inhibitory factor (MIF) tautomerase activity.
    El Turk F; Fauvet B; Ouertatani-Sakouhi H; Lugari A; Betzi S; Roche P; Morelli X; Lashuel HA
    Bioorg Med Chem; 2010 Jul; 18(14):5425-40. PubMed ID: 20639113
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HierVLS hierarchical docking protocol for virtual ligand screening of large-molecule databases.
    Floriano WB; Vaidehi N; Zamanakos G; Goddard WA
    J Med Chem; 2004 Jan; 47(1):56-71. PubMed ID: 14695820
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Virtual medicinal chemistry: in silico pre-docking functional group transformation for discovery of novel inhibitors of botulinum toxin serotype A light chain.
    O'Malley S; Sareth S; Jiao GS; Kim S; Thai A; Cregar-Hernandez L; McKasson L; Margosiak SA; Johnson AT
    Bioorg Med Chem Lett; 2013 May; 23(9):2505-11. PubMed ID: 23545109
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Improving VEGFR-2 docking-based screening by pharmacophore postfiltering and similarity search postprocessing.
    Planesas JM; Claramunt RM; Teixidó J; Borrell JI; Pérez-Nueno VI
    J Chem Inf Model; 2011 Apr; 51(4):777-87. PubMed ID: 21417262
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Advancing fragment binders to lead-like compounds using ligand and protein-based NMR spectroscopy.
    Maurer T
    Methods Enzymol; 2011; 493():469-85. PubMed ID: 21371602
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structure-Based Virtual Screening of Commercially Available Compound Libraries.
    Kireev D
    Methods Mol Biol; 2016; 1439():65-76. PubMed ID: 27316988
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enrichment factor analyses on G-protein coupled receptors with known crystal structure.
    Anighoro A; Rastelli G
    J Chem Inf Model; 2013 Apr; 53(4):739-43. PubMed ID: 23484900
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synergism of virtual screening and medicinal chemistry: identification and optimization of allosteric antagonists of metabotropic glutamate receptor 1.
    Noeske T; Trifanova D; Kauss V; Renner S; Parsons CG; Schneider G; Weil T
    Bioorg Med Chem; 2009 Aug; 17(15):5708-15. PubMed ID: 19574055
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Virtual screening using protein-ligand docking: avoiding artificial enrichment.
    Verdonk ML; Berdini V; Hartshorn MJ; Mooij WT; Murray CW; Taylor RD; Watson P
    J Chem Inf Comput Sci; 2004; 44(3):793-806. PubMed ID: 15154744
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Computer-aided design of GPCR ligands.
    Gutiérrez-de-Terán H; Keränen H; Azuaje J; Rodríguez D; Åqvist J; Sotelo E
    Methods Mol Biol; 2015; 1272():271-91. PubMed ID: 25563191
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 3D QSAR pharmacophore based virtual screening and molecular docking for identification of potential HSP90 inhibitors.
    Sakkiah S; Thangapandian S; John S; Kwon YJ; Lee KW
    Eur J Med Chem; 2010 Jun; 45(6):2132-40. PubMed ID: 20206418
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.